Wealth Enhancement Advisory Services
RDY icon

Wealth Enhancement Advisory Services’s Dr. Reddy's Laboratories RDY Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$50.6K Sell
40,799
-598
-1% -$8.07K ﹤0.01% 3917
2026
Q1 		$78.9K Buy
41,397
+29,834
+258% +$415K ﹤0.01% 3365
2025
Q4 		$162K Buy
11,563
+396
+4% +$5.55K ﹤0.01% 3332
2025
Q3 		$157K Sell
11,167
-3,206
-22% -$46.1K ﹤0.01% 3219
2025
Q2 		$217K Buy
14,373
+464
+3% +$6.63K ﹤0.01% 2916
2025
Q1 		$183K Buy
13,909
+883
+7% +$12.2K ﹤0.01% 2648
2024
Q4 		$206K Buy
+13,026
New +$196K ﹤0.01% 2676

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wealth Enhancement Advisory Services's RDY Position: Q2 2026 in Review

Wealth Enhancement Advisory Services reduced its Dr. Reddy's Laboratories (RDY) stake by 1.4% in Q2 2026, selling an estimated $8.07K and leaving 40,799 shares worth $50.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3917.

Wealth Enhancement Advisory Services first reported a position in RDY in Q4 2024 and has held it in 7 quarters since. The position peaked at $217K in Q2 2025. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • Wealth Enhancement Advisory Services held 40,799 shares of Dr. Reddy's Laboratories worth $50.6K as of Q2 2026.
  • Wealth Enhancement Advisory Services sold 598 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $8.07K.
  • Dr. Reddy's Laboratories made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #3917 holding.
  • Wealth Enhancement Advisory Services first reported a position in Dr. Reddy's Laboratories in Q4 2024 and has held it in 7 quarters since.
  • Wealth Enhancement Advisory Services's Dr. Reddy's Laboratories position peaked at $217K in Q2 2025.
  • 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.